BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17349868)

  • 1. Schizophrenia susceptibility genes: in search of a molecular logic and novel drug targets for a devastating disorder.
    Gogos JA
    Int Rev Neurobiol; 2007; 78():397-422. PubMed ID: 17349868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia genetics: uncovering positional candidate genes.
    Karayiorgou M; Gogos JA
    Eur J Hum Genet; 2006 May; 14(5):512-9. PubMed ID: 16493444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia susceptibility genes: emergence of positional candidates and future directions.
    Gogos JA; Gerber DJ
    Trends Pharmacol Sci; 2006 Apr; 27(4):226-33. PubMed ID: 16530856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How has DISC1 enabled drug discovery?
    Wang Q; Jaaro-Peled H; Sawa A; Brandon NJ
    Mol Cell Neurosci; 2008 Feb; 37(2):187-95. PubMed ID: 18055216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia.
    Williams M
    Curr Opin Investig Drugs; 2003 Jan; 4(1):31-6. PubMed ID: 12625025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling schizophrenia in flies.
    Furukubo-Tokunaga K
    Prog Brain Res; 2009; 179():107-15. PubMed ID: 20302823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of schizophrenia with reference to disrupted-in-schizophrenia 1 (DISC1).
    Matsuzaki S; Tohyama M
    Neurochem Int; 2007; 51(2-4):165-72. PubMed ID: 17664024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of neuropeptide systems in schizophrenia: human studies.
    Cáceda R; Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsychotic pathway genes with expression altered in opposite direction by antipsychotics and amphetamine.
    Ko F; Tallerico T; Seeman P
    Synapse; 2006 Aug; 60(2):141-51. PubMed ID: 16715494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype of schizophrenia: a review and formulation.
    Tamminga CA; Holcomb HH
    Mol Psychiatry; 2005 Jan; 10(1):27-39. PubMed ID: 15340352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic animal models for schizophrenia: advantages and limitations of genetic manipulation in drosophila, zebrafish, rodents, and primates.
    Sawa A
    Prog Brain Res; 2009; 179():3-6. PubMed ID: 20302812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models for schizophrenia via in utero gene transfer: understanding roles for genetic susceptibility factors in brain development.
    Kamiya A
    Prog Brain Res; 2009; 179():9-15. PubMed ID: 20302813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia.
    Morrison PD; Murray RM
    Curr Biol; 2005 Dec; 15(24):R980-4. PubMed ID: 16360673
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in the neurobiology of schizophrenia.
    Miyamoto S; LaMantia AS; Duncan GE; Sullivan P; Gilmore JH; Lieberman JA
    Mol Interv; 2003 Feb; 3(1):27-39. PubMed ID: 14993436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia.
    Zhang HX; Zhao JP; Lv LX; Li WQ; Xu L; Ouyang X; Yuan ZQ; Huang JS
    Neurosci Lett; 2008 Jun; 438(1):1-5. PubMed ID: 18455303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia: diverse approaches to a complex disease.
    Sawa A; Snyder SH
    Science; 2002 Apr; 296(5568):692-5. PubMed ID: 11976442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DISConnectivity in schizophrenia (commentary on Di Giorgio et al.).
    Hall J
    Eur J Neurosci; 2008 Nov; 28(10):2128. PubMed ID: 19046393
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of biomarkers in the discovery of novel anti-schizophrenia drugs.
    Mikkelsen JD; Thomsen MS; Hansen HH; Lichota J
    Drug Discov Today; 2010 Feb; 15(3-4):137-41. PubMed ID: 20036755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations.
    Scolnick EM
    Biol Psychiatry; 2006 Jun; 59(11):1039-45. PubMed ID: 16616720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.